PRESS RELEASE DUBLIN,June 2, 2015/PRNewswire/ –Actavis plc is proud to participate in today'sWhite House Discussion board on Antibiotic Stewardship, which assembles crucial Federal and private sector constituencies mixed up in advancement, promotion, and implementation of antibiotic stewardship activities to ensure the responsible use of antibiotics nationwide .Actavisis dedicated to assisting to bridge the gap between existing treatment plans for serious infections caused by difficult-to-treat pathogens and the advancement of new agents that may help address the urgent threat of antibiotic resistance. Within the company's commitment to antibiotic stewardship,Launched SHARE ID&trade Actavisrecently;, a collaborative system to leverage real-world data to accelerate efforts to address antibiotic resistant infections and advance the delivery and effectiveness of care for patients with serious infections due to antibiotic-resistant pathogens.

Actavis obtains final approval from FDA for generic Subutex Actavis plc today announced that it offers received final authorization from the U.S. Actavis intends to begin shipping its item shortly.S. Product sales of around $108 million, relating to IMS Health data.